Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FUCA1 | P04066 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.57 |
| ▸ | GBA1 | P04062 | 1/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.49 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.48 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.47 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
| ▸ | BCHE | P06276 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30539363 | 1.00 | FUCA1 (0.64) | FUCA1ALDH1A1GBA1CYP1A2CYP3A4 | |
| SCHEMBL1707725 | 0.93 | FUCA1 (0.68) | FUCA1ALDH1A1GBA1GRIN2BS1PR1 | |
| SCHEMBL1707691 | 0.93 | FUCA1 (0.68) | FUCA1ALDH1A1GBA1GRIN2BS1PR1 | |
| SCHEMBL12371118 | 0.93 | FUCA1 (0.68) | FUCA1ALDH1A1GBA1GRIN2BS1PR1 | |
| SCHEMBL1707693 | 0.93 | FUCA1 (0.68) | FUCA1ALDH1A1GBA1GRIN2BS1PR1 | |
| SCHEMBL694003 | 0.93 | FUCA1 (0.68) | FUCA1ALDH1A1GBA1GRIN2BS1PR1 | |
| SCHEMBL15082004 | 0.89 | FUCA1 (0.56) | FUCA1ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL14157505 | 0.89 | FUCA1 (0.56) | FUCA1ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL14157508 | 0.89 | FUCA1 (0.56) | FUCA1ALDH1A1CYP1A2CYP3A4CYP2D6 | |
| SCHEMBL500532 | 0.89 | FUCA1 (0.56) | FUCA1ALDH1A1CYP1A2CYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110818704-B | Spiro bridged ring compounds, pharmaceutical compositions thereof and uses thereof | 广州市恒诺康医药科技有限公司 | 2023-08-01 | — | — | CN | disclosed |
| WO-2021026375-A1 | FUSED BICYCLIC COMPOUNDS FOR THE TREATMENT OF PAIN | ALKERMES, INC. (US) | 2021-02-11 | — | — | WO | disclosed |
| US-20210024493-A1 | Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity | THERAVANCE RESPIRATORY COMPANY, LLC | 2021-01-28 | — | — | US | disclosed |
| US-10836744-B2 | Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity | THERAVANCE RESPIRATORY COMPANY, LLC (US) | 2020-11-17 | — | — | US | disclosed |
| US-20200165223-A1 | Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity | THERAVANCE RESPIRATORY COMPANY, LLC | 2020-05-28 | — | — | US | disclosed |
| US-10590107-B2 | Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity | THERAVANCE RESPIRATORY COMPANY, LLC (US) | 2020-03-17 | — | — | US | disclosed |
| US-20190300504-A1 | Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity | THERAVANCE RESPIRATORY COMPANY, LLC | 2019-10-03 | — | — | US | disclosed |
| US-10358433-B2 | Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity | THERAVANCE RESPIRATORY COMPANY, LLC (US) | 2019-07-23 | — | — | US | disclosed |
| US-20190047984-A1 | Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity | THERAVANCE RESPIRATORY COMPANY, LLC | 2019-02-14 | — | — | US | disclosed |
| US-20190002452-A1 | FXR RECEPTOR MODULATOR, PREPARATION METHOD THEREFOR, AND USES THEREOF | GUANGZHOU HENOVCOM BIOSCIENCE CO. LTD. (CN) | 2019-01-03 | — | — | US | disclosed |
| US-7485727-B2 | Cyclic amine compound and pest control agent | NIPPON SODA CO., LTD. (JP) | 2009-02-03 | — | — | US | disclosed |
| US-7485727-B2 | Cyclic amine compound and pest control agent | NIPPON SODA CO., LTD. (JP) | 2009-02-03 | — | — | US | disclosed |
| US-7485727-B2 | Cyclic amine compound and pest control agent | NIPPON SODA CO., LTD. (JP) | 2009-02-03 | — | — | US | disclosed |
| US-20080319003-A1 | CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2008-12-25 | — | — | US | disclosed |
| US-20080319003-A1 | CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2008-12-25 | — | — | US | disclosed |
| US-20080319003-A1 | CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2008-12-25 | — | — | US | disclosed |
| US-20080045569-A1 | Cyclic Amine Compound and Pest Control Agent | NIPPON SODA CO., LTD. (JP) | 2008-02-21 | — | — | US | disclosed |
| US-20080045569-A1 | Cyclic Amine Compound and Pest Control Agent | NIPPON SODA CO., LTD. (JP) | 2008-02-21 | — | — | US | disclosed |
| US-20080045569-A1 | Cyclic Amine Compound and Pest Control Agent | NIPPON SODA CO., LTD. (JP) | 2008-02-21 | — | — | US | disclosed |
| EP-1731518-A1 | CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT | NIPPON SODA CO., LTD. (JP) | 2006-12-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190300504-A1 | Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity | ADRB2, ADRB1, ADRA2B | FUCA1 3013/4885ALDH1A1 1263/4885GBA1 2484/4885 |
| US-20190002452-A1 | FXR RECEPTOR MODULATOR, PREPARATION METHOD THEREFOR, AND USES THEREOF | NR1H4, FXR1, GPBAR1 | FUCA1 1653/4885ALDH1A1 3079/4885GBA1 3003/4885 |
| US-10836744-B2 | Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity | ADRB2, ADRB1, ADRA2A | FUCA1 2930/4885ALDH1A1 1282/4885GBA1 2647/4885 |
| US-20080045569-A1 | Cyclic Amine Compound and Pest Control Agent | H1-0, H1-2, H1-4 | FUCA1 4812/4885ALDH1A1 2751/4885GBA1 4031/4885 |
| US-20210024493-A1 | Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity | ADRB2, ADRB1, ADRA2B | FUCA1 3281/4885ALDH1A1 1382/4885GBA1 2111/4885 |
| US-10590107-B2 | Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity | ADRB2, ADRB1, ADRA2B | FUCA1 3013/4885ALDH1A1 1263/4885GBA1 2484/4885 |
| US-20190047984-A1 | Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity | ADRB2, ADRB1, ADRA2B | FUCA1 3045/4885ALDH1A1 1356/4885GBA1 2497/4885 |
| US-20080319003-A1 | CYCLIC AMINE COMPOUND AND PEST CONTROL AGENT | H1-0, H1-2, H1-4 | FUCA1 4813/4885ALDH1A1 2736/4885GBA1 4096/4885 |
| US-20200165223-A1 | Diamide Compounds Having Muscarinic Receptor Antagonist and Beta2 Adrenergic Receptor Agonist Activity | ADRB2, ADRB1, ADRA2B | FUCA1 3013/4885ALDH1A1 1263/4885GBA1 2484/4885 |
| US-10358433-B2 | Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity | ADRB2, ADRB1, ADRA2A | FUCA1 2986/4885ALDH1A1 1297/4885GBA1 2737/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.